comparemela.com
Home
Live Updates
Triveni emerges from biotech merger with $92M for immune dis
Triveni emerges from biotech merger with $92M for immune dis
Triveni emerges from biotech merger with $92M for immune disease drugs
BioPharma
Related Keywords
Massachusetts ,
United States ,
Alexandria ,
Al Iskandariyah ,
Egypt ,
Waltham ,
Triveni Bio ,
Amgen Enbrel ,
Nicholas Scarchilli ,
Vishal Patel ,
Jennifer Dovey ,
Abbvie Humira ,
Tillman Gerngross ,
Abbvie Rinvoq ,
Bristol Myers Squibb Sotyktu ,
Vanderbilt University Medical Center ,
Atlas Venture ,
Dive Brief ,
Amagma Therapeutics ,
Modify Therapeutics ,
Cormorant Asset ,
Bristol Myers Squibb ,
Nashville Biosciences ,
Vanderbilt University Medical ,
Viking Global Investors ,
Polaris Partners ,
Alexandria Venture Investments ,
Biotech ,